| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,181 |
5,347 |
$660K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,505 |
3,756 |
$634K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,974 |
2,399 |
$540K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,671 |
1,386 |
$400K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,249 |
1,956 |
$202K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,028 |
3,079 |
$123K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,330 |
1,855 |
$71K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
332 |
277 |
$70K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
437 |
358 |
$68K |
| 81025 |
|
2,296 |
1,931 |
$58K |
| 80053 |
Comprehensive metabolic panel |
2,644 |
2,058 |
$55K |
| 99205 |
Prolong outpt/office vis |
564 |
323 |
$46K |
| 70450 |
Computed tomography, head or brain; without contrast material |
739 |
594 |
$44K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,346 |
4,719 |
$36K |
| 81001 |
|
3,647 |
2,917 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
427 |
308 |
$30K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
552 |
358 |
$26K |
| 87631 |
|
248 |
230 |
$26K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
929 |
777 |
$21K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,827 |
2,119 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
2,585 |
2,074 |
$20K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
217 |
183 |
$20K |
| 59025 |
Fetal non-stress test |
285 |
199 |
$18K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
115 |
89 |
$18K |
| 80305 |
|
560 |
462 |
$17K |
| 84484 |
|
2,219 |
1,412 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
1,727 |
1,250 |
$16K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
267 |
241 |
$15K |
| 80076 |
|
1,434 |
1,190 |
$12K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,278 |
1,012 |
$12K |
| 83690 |
|
1,408 |
1,149 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,312 |
1,021 |
$12K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
439 |
341 |
$11K |
| 87088 |
|
1,449 |
1,192 |
$11K |
| 71046 |
Radiologic examination, chest; 2 views |
501 |
409 |
$10K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
929 |
793 |
$10K |
| 81003 |
|
667 |
565 |
$9K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
22 |
12 |
$7K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
766 |
633 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
64 |
52 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
383 |
311 |
$4K |
| 87430 |
|
373 |
325 |
$4K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
120 |
102 |
$3K |
| 85610 |
|
861 |
656 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
846 |
691 |
$3K |
| 82962 |
|
150 |
115 |
$3K |
| 80061 |
Lipid panel |
56 |
49 |
$2K |
| 82150 |
|
311 |
254 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
221 |
164 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
40 |
25 |
$1K |
| 83880 |
|
125 |
95 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
28 |
25 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
15 |
12 |
$956.67 |
| 82565 |
|
94 |
76 |
$795.84 |
| 80051 |
|
87 |
70 |
$715.55 |
| 84520 |
|
87 |
70 |
$715.55 |
| 82310 |
|
86 |
69 |
$715.55 |
| 82947 |
|
87 |
69 |
$715.55 |
| 84443 |
Thyroid stimulating hormone (TSH) |
93 |
80 |
$709.52 |
| 85730 |
|
292 |
211 |
$461.45 |
| 87077 |
|
31 |
24 |
$303.10 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
77 |
61 |
$295.12 |
| 87081 |
|
47 |
43 |
$285.04 |
| 85027 |
|
50 |
40 |
$221.00 |
| 85007 |
|
29 |
25 |
$190.27 |
| 87186 |
|
63 |
51 |
$173.48 |
| 82550 |
|
63 |
40 |
$147.74 |
| 82553 |
|
42 |
25 |
$146.27 |
| 85652 |
|
14 |
13 |
$97.40 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
17 |
12 |
$81.35 |
| 83735 |
|
35 |
28 |
$55.15 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
14 |
12 |
$42.04 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
43 |
37 |
$0.00 |
| 86901 |
|
19 |
13 |
$0.00 |
| 84704 |
|
19 |
15 |
$0.00 |
| 84702 |
|
14 |
12 |
$0.00 |